Cancer Plus (ISSN: 2661-3840)

Description

Cancer Plus is a new research journal that aims to provide a peer-reviewed, open-access platform for researchers and practitioners to present novel and high-impact articles in the field of cancer research and clinical trials. This is a joint collaboration journal between Shan'xi Academy of Medical Sciences (China), Shan'xi Bethune Hospital (China), and the Chinese Academy of Sciences. Areas of interest for this journal include, but are not limited to, the following topics:
Mechanisms of tumorigenesis
Genetic alterations of cancer
Epigenetics of cancer
Cell signalling
Cancer stem cells
Cancer prevention
Diagnosis
Cancer drugs/chemotherapy/therapeutic methods
Clinical trials